KELLANOVA (K)
(Delayed Data from NYSE)
$81.05 USD
+0.03 (0.04%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $81.06 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$81.05 USD
+0.03 (0.04%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $81.06 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Zacks News
Hershey (HSY) Q3 Earnings Upcoming: Here's All You Should Note
by Zacks Equity Research
Hershey's (HSY) third-quarter 2022 performance will likely reflect gains from prudent acquisitions and strategic pricing efforts. However, rising cost inflation is likely to have been a concern.
Darling Ingredients (DAR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Darling (DAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors to Affect Monster Beverage's (MNST) Q3 Earnings
by Zacks Equity Research
Monster Beverage's (MNST) Q3 results are expected to reflect the impacts of higher input costs and elevated freight. Strength in energy drinks and product launches are likely to have been upsides.
Medifast's (MED) Q3 Earnings Upcoming: Things Worth Noting
by Zacks Equity Research
Medifast's (MED) third-quarter 2022 results are likely to reflect cost-related challenges, whereas strength in the OPTAVIA lifestyle solution and coaching support system bodes well.
What Awaits The Estee Lauder Companies (EL) in Q1 Earnings?
by Zacks Equity Research
The Estee Lauder Companies (EL) Q1 performance will likely reflect adverse impacts from record inflation and supply chain disruptions. That said, strength in online sales is a breather.
Nu Skin (NUS) Queued for Q3 Earnings: Things to Consider
by Zacks Equity Research
Nu Skin's (NUS) Q3 performance will likely reflect continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
Kellogg's (K) Q3 Earnings Upcoming: Here's All You Should Note
by Zacks Equity Research
Kellogg's (K) third-quarter 2022 results are likely to reflect gains from the company's revenue growth management actions, whereas cost inflation and supply-chain bottlenecks are likely to have been a concern.
Sysco's (SYY) Q1 Earnings Upcoming: Key Factors to Note
by Zacks Equity Research
Sysco's (SYY) first-quarter fiscal 2023 results are likely to reflect gains from the Recipe for Growth program and a diversified model, whereas high costs might have been a concern.
Service Corporation (SCI) to Report Q3 Earnings: Things to Note
by Zacks Equity Research
Service Corporation's (SCI) third-quarter 2022 performance will likely reflect the adverse impact of rising inflationary pressure. Strength in the funeral segment has been an upside.
Factors Likely to Influence Molson Coors' (TAP) Earnings in Q3
by Zacks Equity Research
Molson Coors' (TAP) Q3 results are likely to reflect gains from positive pricing and favorable brand and channel mix stemming from portfolio premiumization and reduced on-premise channel restrictions.
Here's Why Clorox (CLX) is Poised to Top Q1 Earnings Estimates
by Zacks Equity Research
Clorox's (CLX) first-quarter fiscal 2023 results are likely to reflect gains from the IGNITE strategy and pricing actions, whereas elevated inflation concerns are likely to have acted as deterrents.
Kellogg (K) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Kellogg (K) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Mondelez's (MDLZ) Q3 Earnings Upcoming: Key Things to Note
by Zacks Equity Research
Mondelez's (MDLZ) third-quarter 2022 results are likely to reflect gains from buyouts, whereas input cost inflation and supply-chain woes are likely to have been a concern.
Church & Dwight (CHD) Q3 Earnings Upcoming: Key Things to Note
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter 2022 results are likely to reflect raw material cost inflation, high SG&A expenses and a slowdown in discretionary brands, while pricing actions are likely to have been an upside.
Can Colgate (CL) Beat Q3 Earnings Estimates Amid Cost Woes?
by Zacks Equity Research
Colgate's (CL) Q3 results are expected to reflect gains from strong demand, brand strength, innovation and digital growth, offset by higher raw material and logistic costs.
Things You Need to Know Before FEMSA's (FMX) Q3 Earnings
by Zacks Equity Research
FEMSA's (FMX) Q3 results are expected to reflect gains from strength across businesses, owing to effective growth strategies and robust demand across markets, amid supply-chain and inflation woes.
Things You Need to Know Before Newell's (NWL) Q3 Earnings
by Zacks Equity Research
Inflationary pressure and fewer retail orders are likely to have hurt Newell's (NWL) Q3 performance. Online strength, strong demand and core sales growth are likely to have aided.
Kellogg (K) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Kellogg (K) closed at $74.09 in the latest trading session, marking a +1.27% move from the prior day.
Altria's (MO) Q3 Earnings Upcoming: Key Factors to Note
by Zacks Equity Research
Altria's (MO) third-quarter 2022 results are likely to reflect gains from pricing and strength in the oral tobacco products space, while cost inflation may have been a concern.
Will Pricing Aid Keurig's (KDP) Q3 Earnings Amid Cost Woes?
by Zacks Equity Research
A recovery in the supply chain of coffee and non-carbonated beverages, pricing gains to mitigate inflation, and continued portfolio growth are likely to aid Keurig's (KDP) Q3 results amid cost woes.
Kraft Heinz (KHC) Q3 Earnings Upcoming: Key Factors to Note
by Zacks Equity Research
Kraft Heinz's (KHC) third-quarter 2022 results are likely to reflect the adverse impact of escalated costs, while pricing actions and a focus on the operating model bode well.
Kimberly-Clark (KMB) Q3 Earnings Coming Up: Things to Note
by Zacks Equity Research
Kimberly-Clark's (KMB) third-quarter 2022 performance will likely reflect elevated input costs. Also, unfavorable currency translations are a hurdle.
Pilgrim's Pride (PPC) Q3 Earnings Upcoming: Factors to Note
by Zacks Equity Research
Pilgrim's Pride's (PPC) third-quarter 2022 results are likely to reflect gains from the company's customer-centric approach, marketing efforts and supply-chain enhancements amid cost inflation.
Kellogg (K) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Kellogg (K) closed at $73.58 in the latest trading session, marking a +0.12% move from the prior day.